Back to top
more

Inspire Medical Systems (INSP)

(Delayed Data from NYSE)

$190.71 USD

190.71
747,942

-4.33 (-2.22%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $190.90 +0.19 (0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Medical Info Systems

Better trading starts here.

Balance Sheet

Research for INSP

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Inspire Medical Systems, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 460 451 214 234 149
Receivables 90 61 34 25 13
Notes Receivable 0 0 0 0 0
Inventories 34 12 17 8 6
Other Current Assets 10 6 3 2 2
Total Current Assets 594 530 269 270 171
Net Property & Equipment 40 17 8 5 3
Investments & Advances 9 0 10 0 6
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 0 0 0 0 0
Deposits & Other Assets 11 11 0 0 0
Total Assets 677 565 295 281 181
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 9 0 0
Accounts Payable 39 27 12 7 4
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 39 34 20 14 12
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 78 61 41 21 17
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 16 25 25
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1 0 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 104 69 66 51 41
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 917 820 508 467 320
Retained Earnings -345 -324 -279 -237 -180
Other Equity 1 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 573 496 229 230 140
Total Liabilities & Shareholder's Equity 677 565 295 281 181
Total Common Equity 573 496 229 230 140
Shares Outstanding 29.50 28.80 27.30 26.90 24.00
Book Value Per Share 19.41 17.22 8.39 8.54 5.83

Fiscal Year End for Inspire Medical Systems, Inc falls in the month of December.

All items in Millions except Per Share data.

9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Assets          
Cash & Equivalents -99,999 440 441 460 464
Receivables NA 80 72 90 71
Notes Receivable NA 0 0 0 0
Inventories NA 59 49 34 26
Other Current Assets NA 29 10 10 8
Total Current Assets NA 607 572 594 570
Net Property & Equipment NA 62 52 40 32
Investments & Advances NA 26 28 9 3
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 0 0 0 0
Deposits & Other Assets NA 11 11 11 12
Total Assets NA 728 686 677 639
Liabilities & Shareholders Equity 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 34 44 39 40
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 32 28 39 30
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 66 72 78 70
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 0 1 0
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 90 97 104 95
Shareholders Equity 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 984 944 917 904
Retained Earnings NA -346 -355 -345 -360
Other Equity NA 0 0 1 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 638 589 573 544
Total Liabilities & Shareholder's Equity NA 728 686 677 639
Total Common Equity 0 638 589 573 544
Shares Outstanding 29.80 29.70 30.30 29.50 29.30
Book Value Per Share 0.00 21.48 19.44 19.41 18.57